FOLR2 and cancer: FRα has a relatively broad tissue distribution profile in normal cells (e.g., kidney) and cancer cells (e.g., ovarian carcinoma cells) [76], whereas FRβ expression is restricted to hematopoietic cells of the myeloid lineage [77, 78].